MEX3A在非小细胞肺癌中的表达与功能研究

朱贝 郭小朋 董天祺 肖春杰

朱贝, 郭小朋, 董天祺, 肖春杰. MEX3A在非小细胞肺癌中的表达与功能研究[J]. 中国肿瘤临床, 2020, 47(15): 763-768. doi: 10.3969/j.issn.1000-8179.2020.15.571
引用本文: 朱贝, 郭小朋, 董天祺, 肖春杰. MEX3A在非小细胞肺癌中的表达与功能研究[J]. 中国肿瘤临床, 2020, 47(15): 763-768. doi: 10.3969/j.issn.1000-8179.2020.15.571
Bei Zhu, Xiaopeng Guo, Tianqi Dong, Chunjie Xiao. Expression level and function of MEX3A in non-small cell lung cancer[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 47(15): 763-768. doi: 10.3969/j.issn.1000-8179.2020.15.571
Citation: Bei Zhu, Xiaopeng Guo, Tianqi Dong, Chunjie Xiao. Expression level and function of MEX3A in non-small cell lung cancer[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 47(15): 763-768. doi: 10.3969/j.issn.1000-8179.2020.15.571

MEX3A在非小细胞肺癌中的表达与功能研究

doi: 10.3969/j.issn.1000-8179.2020.15.571
基金项目: 

国家自然科学基金项目 81860499

详细信息
    作者简介:

    朱贝专  业方向为肿瘤遗传与分子机理的相关研究。E-mail:2671668602@qq.com

    通讯作者:

    肖春杰  chjxiao@ynu.edu.cn

Expression level and function of MEX3A in non-small cell lung cancer

Funds: 

National Natural Science Foundation of China 81860499

More Information
  • 摘要:   目的  探究MEX3A基因在非小细胞肺癌(non-small cell lung cancer,NSCLC)中的表达水平及沉默MEX3A基因后对NSCLC增殖、侵袭、迁移和凋亡及周期的影响。  方法  通过mRNA转录组分析及癌症基因图谱(The Cancer Genome Atlas,TCGA)数据库信息分析,筛选出在NSCLC中显著高表达的MEX3A基因。通过qRT-PCR检测MEX3A在4种常见NSCLC细胞系中的mRNA表达水平,发现MEX3A在A549和NCI-H292中显著高表达。利用RNA干扰技术(RNA interference,RNAi)沉默A549和NCI-H292中MEX3A的表达,CCK8及Transwell试验检测沉默MEX3A表达后对NSCLC增殖、侵袭及迁移的影响,流式细胞术分析沉默MEX3A表达后对A549和NCI-H292细胞周期及凋亡的影响。  结果  MEX3A在A549和NCI-H292中高表达。沉默MEX3A后NSCLC增殖、侵袭及迁移被显著抑制,细胞周期阻滞于G2/M期,促进细胞凋亡。  结论  MEX3A作为NSCLC的促癌基因,参与了NSCLC的生长及增殖过程。

     

  • 图  1  MEX3A在NSCLC中高表达

    A:TCGA数据库数据统计分析显示与正常组织样本(n=20)相比,MEX3A mRNA在肺腺癌组织(n=226)中显著高表达;B:RT-qPCR结果显示A549和NCIH292的MEX3A mRNA表达水平显著高于正常癌旁细胞BEAS-2B;C:qRT-PCR结果显示沉默MEX3A基因后A549和NCI-H292的mRNA表达水平显著降低;***:P<0.001

    图  2  沉默MEX3A基因后抑制NSCLC的增殖

    图  3  沉默MEX3A基因后抑制NSCLC的侵袭及迁移

    ***:P<0.001

    图  4  沉默MEX3A基因后诱导NSCLC细胞凋亡

    *:P<0.05;***:P<0.001

    图  5  沉默MEX3A基因后阻滞NSCLC细胞周期

    ***:P<0.001

    表  1  引物序列

    表  2  新鲜组织样本临床病理资料

    表  3  mRNA转录组芯片筛选出在NSCLC中上调的mRNAs

  • [1] Wen C, Dehnel T. China wrestles with lung cancer[J]. Lancet Oncol, 2011, 12(1):15. doi: 10.1016/S1470-2045(10)70303-X
    [2] Travis WD, Brambilla E, Nicholson AG, et al. The 2015 World Health Organization Classification of lung tumors:impact of genetic, clinical and radiologic advances since the 2004 classification[J]. J Thorac Oncol, 2015, 10(9):1243-1260. doi: 10.1097/JTO.0000000000000630
    [3] Buchet-poyau K, Coerchet J, Le hir H, et al. Identification and characterization of human Mex-3 proteins, a novel family of evolutionarily conserved RNA-binding proteins differentially localized to processing bodies[J]. Nucleic Acids Res, 2007, 35(4):1289-1300. doi: 10.1093/nar/gkm016
    [4] Valverde R, Edwards L, Regan L. Structure and function of KH domains[J]. FEBS J, 2008, 275(11):2712-2726. doi: 10.1111/j.1742-4658.2008.06411.x
    [5] Cano F, Bye H, Duncan LM, et al. The RNA-binding E3 ubiquitin ligase MEX-3C links ubiquitination with MHC-I mRNA degradation[J]. EMBO J, 2012, 31(17):3596-3606. doi: 10.1038/emboj.2012.218
    [6] Jiang H, Zhang X, Luo J, et al. Knockdown of hMex-3A by small RNA interference suppresses cell proliferation and migration in human gastric cancer cells[J]. Mol Med Rep, 2012, 6(3):575-580. http://cn.bing.com/academic/profile?id=c8c0a41133e1453e029ceb4d2f40e5e9&encoded=0&v=paper_preview&mkt=zh-cn
    [7] Krepischi ACV, Maschietto M, Ferreira EN, et al. Genomic imbalances pinpoint potential oncogenes and tumor suppressors in Wilms tumors[J]. Mol Cytogenet, 2016, 9:20. doi: 10.1186/s13039-016-0227-y
    [8] Shi JW, Huang Y. Mex3a expression and survival analysis of bladder urothelial carcinoma[J]. Oncotarget, 2017, 8(33):54764-54774. doi: 10.18632/oncotarget.18399
    [9] Yang DJY, Li Y, Fang X. Clinical characteristics and prognostic value of MEX3A mRNA in liver cancer[J]. PeerJ, 2020, 8:e8252. doi: 10.7717/peerj.8252
    [10] 徐嵩, 赵世康, 任凡, 等.非小细胞肺癌新辅助靶向及免疫治疗研究进展和展望[J].中国肿瘤临床, 2020, 47(6):299-303. doi: 10.3969/j.issn.1000-8179.2020.06.151
    [11] Pao W, Girard N. New driver mutations in non-small cell lung cancer[J]. Lancet Oncol, 2011, 12(2):175-180. doi: 10.1016/S1470-2045(10)70087-5
    [12] Draper BW, Mello CC, Bowerman B, et al. MEX-3 is a KH domain protein that regulates blastomere identity in early C. elegans embryos[J]. Cell, 1996, 87(2):205-216. doi: 10.1016/S0092-8674(00)81339-2
    [13] Sheth U, Parker R. Decapping and decay of messenger RNA occur in cytoplasmic processing bodies[J]. Science, 2003, 300(5620):805-808. doi: 10.1126/science.1082320
    [14] Teixeira D, Sheth U, Valencin-Sanchez MA, et al. Processing bodies require RNA for assembly and contain nontranslating mRNAs[J]. RNA, 2005, 11(4):371-382. doi: 10.1261/rna.7258505
    [15] 陈云云, 房超, 于秋爽, 等.MEX3A在人膀胱癌组织细胞中的表达及分析[J].生物医学工程与临床, 2018, 22(1):82-86. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=swyxgcylc201801020
    [16] 房超, 尹晶, 于秋爽, 等.RNA干扰MEX3A基因对膀胱癌细胞增殖和凋亡的影响[J].解剖学报, 2017, 48(6):688-692. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=jpxb201706011
    [17] Pereira B, Sousa S, Barros R, et al. CDX2 regulation by the RNA-binding protein MEX3A:impact on intestinal differentiation and stemness[J]. Nucleic Acids Res, 2013, 41(7):3986-3999. doi: 10.1093/nar/gkt087
  • 加载中
图(5) / 表(3)
计量
  • 文章访问数:  143
  • HTML全文浏览量:  4
  • PDF下载量:  22
  • 被引次数: 0
出版历程
  • 收稿日期:  2020-05-08
  • 刊出日期:  2020-12-26

目录

    /

    返回文章
    返回